Concord Medical Services Holdings Limited
CCM
$5.32
-$0.15-2.74%
NYSE
| 12/31/2025 | 09/30/2025 | 12/31/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 59.69% | 57.41% | -34.45% | -25.58% | -26.71% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 59.69% | 57.41% | -34.45% | -25.58% | -26.71% |
| Cost of Revenue | 15.03% | 13.38% | -30.34% | -21.73% | -22.91% |
| Gross Profit | 181.31% | 180.14% | 3.77% | -7.55% | -5.93% |
| SG&A Expenses | -57.34% | -57.96% | 42.04% | -14.44% | -15.74% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -27.98% | -29.01% | -0.08% | -19.15% | -20.37% |
| Operating Income | 71.27% | 71.68% | -34.83% | 10.60% | 11.95% |
| Income Before Tax | 42.64% | 43.47% | -3.61% | -39.66% | -37.54% |
| Income Tax Expenses | -57.66% | -55.38% | -666.29% | 64.16% | 64.70% |
| Earnings from Continuing Operations | 45.38% | 46.17% | -1.21% | -51.21% | -48.93% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -41.31% | -42.15% | 64.98% | 26.83% | 24.91% |
| Net Income | 50.99% | 51.69% | 33.96% | -83.20% | -80.43% |
| EBIT | 71.27% | 71.68% | -34.83% | 10.60% | 11.95% |
| EBITDA | 90.79% | 87.59% | -45.02% | 12.19% | 13.52% |
| EPS Basic | 50.99% | 51.70% | 33.96% | -83.19% | -80.42% |
| Normalized Basic EPS | 123.65% | 123.29% | 75.81% | -- | -- |
| EPS Diluted | 51.20% | 51.90% | 33.86% | -83.19% | -80.42% |
| Normalized Diluted EPS | 123.65% | 123.29% | 75.81% | -- | -- |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |